Cargando…
New Insights into the Androgen-Targeted Therapies and Epigenetic Therapies in Prostate Cancer
Prostate cancer is the most common cancer in men in the United States, and it is the second leading cause of cancer-related death in American men. The androgen receptor (AR), a receptor of nuclear family and a transcription factor, is the most important target in this disease. While most efforts in...
Autores principales: | Godbole, Abhijit M., Njar, Vincent C. O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3196248/ https://www.ncbi.nlm.nih.gov/pubmed/22111003 http://dx.doi.org/10.1155/2011/918707 |
Ejemplares similares
-
Overview on the complexity of androgen receptor-targeted therapy for prostate cancer
por: Farooqi, Ammad Ahmad, et al.
Publicado: (2015) -
Simultaneous targeting of androgen receptor (AR) and MAPK-interacting kinases (MNKs) by novel retinamides inhibits growth of human prostate cancer cell lines
por: Ramamurthy, Vidya P., et al.
Publicado: (2014) -
Novel Insights on the Role of Epigenetics in Androgen Receptor’s Expression in Prostate Cancer
por: Camilo, Vânia, et al.
Publicado: (2023) -
Androgens as therapy for androgen receptor-positive castration-resistant prostate cancer
por: Chuu, Chih-Pin, et al.
Publicado: (2011) -
Targeting androgen receptor-independent pathways in therapy-resistant prostate cancer
por: Xu, Lingfan, et al.
Publicado: (2019)